Homepage

GRAIL Inc.

GRAL NASDAQ Categories PDF
Healthcare · Biotechnology
Menlo Park, CA 94025, United States IPO 2024 grail.com Updated Jul 3, 3:00am
Price
$69.11
Market Cap
$3.0B
Employees
910
Beta
3.16
Avg Volume
764,529
CEO
Robert Ragusa
Business Description

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.

Business History
Price Overview
Price at report time · Jul 3, 4:52am (0m ago)
$69.11
Change · Jul 3
+1.00 (+1.47%)
Day Range
$67.63 – $71.41
52-Week Range
$29.95 – $118.84
50-Day MA
$61.66
200-Day MA
$72.77
Volume
337,476.00
Right now · live
loading…
 
Real-time — the change above is the move since the report (over 0m).
Analyst Price Targets
Low $56.00
Consensus $73.43
High $130.00
(15 analysts)
Share Structure
Outstanding 42,916,590.00
Float 39,293,485.00
Free Float 91.6%
High free float — 91.6% of shares trade freely, ~8.4% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jul 3, 2026 4:52am (just now)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jul 3, 2026 4:52am (just now)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALC
Stock Price / EPS (Diluted)
-6.22
Stock Price: $69.11
EPS (Diluted): -11.11
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
1.22
Stock Price: $69.11
Total Equity: $2.58B
Shares: 36,753,751
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
-8.73
Market Cap: $2.97B
Total Debt: $54.86M
Cash: $249.73M
EBITDA: -$378.16M
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$3.0B
Market Cap: $2.97B
Total Debt: $54.86M
Cash: $249.73M
P/S Ratio (Price per dollar of revenue)
API
Stock Price / Revenue Per Share
21.37
Stock Price: $69.11
Revenue: $147.17M
Shares: 36,753,751
EV/Sales (Total value vs revenue — works when P/E can't)
API
20.34
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
-42.5%
Gross Profit: -$62.57M
Revenue: $147.17M
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
-363.0%
Operating Income: -$534.16M
Revenue: $147.17M
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
-277.5%
Net Income: -$408.35M
Revenue: $147.17M
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
-16.4%
Net Income: -$408.35M
Total Equity: $2.58B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
-15.2%
Operating Income: -$534.16M
Tax Rate: 23.6%
Equity: $2.58B
Total Debt: $54.86M
Cash: $249.73M
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
11.97
Current Assets: $953.85M
Current Liabilities: $79.67M
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.02
Short-Term Debt: $11.72M
Long-Term Debt: $43.15M
Total Debt: $54.86M
Total Equity: $2.58B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$4.00
Revenue: $147.17M
Shares: 36,753,751
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$70.14
Total Equity: $2.58B
Shares: 36,753,751
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$-8.16
Operating CF: -$299.01M
CapEx: -$909,000
Shares: 36,753,751
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $69.11
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: -$408.35M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares GRAL against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
4h Dividend Discount Model — For dividend/income stocks only
4i Book Value Analysis — For deep value / turnaround stocks only
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jul 3, 2026 4:52am (just now)
Metric 2021 2022 2023 2024 2025
Revenue $14.6M $55.6M $93.1M $125.6M $147.2M
Cost of Revenue $114.6M $172.0M $188.7M $203.6M $209.7M
Gross Profit -$100.0M -$116.4M -$95.6M -$78.0M -$62.6M
Operating Expenses $1.2B $5.3B $1.4B $2.1B $471.6M
Operating Income -$1.3B -$5.4B -$1.5B -$2.2B -$534.2M
Net Income -$1.2B -$5.4B -$1.5B -$2.0B -$408.4M
EBITDA -$1.2B -$587.7M -$638.2M -$610.2M -$378.2M
EPS $-40.18 $-173.87 $-47.20 $-63.54 $-11.11
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jul 3, 2026 4:52am (just now)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $221.2M $241.6M $97.3M $214.2M $249.7M
Total Current Assets $242.7M $295.6M $156.1M $819.9M $953.8M
Total Assets $9.7B $5.6B $4.6B $3.0B $2.9B
Current Liabilities $97.9M $134.9M $163.6M $76.9M $79.7M
Long-Term Debt $0 $0 $0 $0 $43.1M
Total Liabilities $307.4M $955.9M $910.7M $479.9M $344.2M
Total Equity $9.4B $4.6B $3.6B $2.5B $2.6B
Retained Earnings -$911.5M -$6.3B -$7.8B -$9.8B -$10.2B
Cash Flow (Annual)
Last updated: Jul 3, 2026 4:52am (just now)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow -$688.1M -$561.3M -$595.8M -$577.2M -$299.0M
Capital Expenditure -$69.9M -$22.9M -$12.9M -$5.2M $-909,000
Free Cash Flow -$758.1M -$584.2M -$608.7M -$582.4M -$299.0M
Acquisitions (net) $0 $0 $0 $0 $0
Debt Repayment
Dividends Paid
Stock Buybacks $-170,000 $0 $0 $0 $0
Net Change in Cash -$143.2M $20.1M -$144.6M $116.1M $39.1M
Analyst Estimates (Annual)
Last updated: Jul 3, 2026 4:52am (just now)
Metric 2027 2028 2029 2030
Revenue $223.5M
$202.6M – $247.4M
$286.5M
$286.5M – $286.5M
$377.7M
$352.5M – $407.7M
$492.5M
$459.6M – $531.6M
EBITDA -$223.5M
-$247.4M – -$202.6M
-$286.5M
-$286.5M – -$286.5M
-$377.7M
-$407.7M – -$352.5M
-$492.5M
-$531.6M – -$459.6M
Net Income -$389.1M
-$404.5M – -$373.7M
-$442.1M
-$489.8M – -$292.3M
-$388.6M
-$428.8M – -$355.0M
-$351.5M
-$387.8M – -$321.0M
EPS
Growth Trends (YoY %)
Last updated: Jul 3, 2026 4:52am (just now)
Metric 2022 2023 2024 2025
Revenue Growth +280.2% +67.6% +34.9% +17.2%
Gross Profit Growth -16.4% +17.9% +18.4% +19.8%
Operating Income Growth -330.2% +72.2% -44.5% +75.6%
Net Income Growth -332.7% +72.9% -38.3% +79.9%
EBITDA Growth +51.3% -8.6% +4.4% +38.0%
Insider Trading (Recent)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-06-18 CHASE WILLIAM J A-Award 5,491.00 $63.74 $349,996
2026-06-18 MIZELL STEVEN A-Award 5,491.00 $63.74 $349,996
2026-06-18 SUMME GREGORY L A-Award 5,491.00 $63.74 $349,996
2026-06-18 Krevans Sarah A-Award 5,491.00 $63.74 $349,996
2026-06-04 Partridge Andrew John S-Sale 1,491.00 $61.08 $91,070
2026-06-03 Ofman Joshua J. A-Award 3,154.00 $61.13 $192,804
2026-06-01 Ofman Joshua J. A-Award 27,901.00 $64.40 $1.8M
2026-06-01 Partridge Andrew John 0.00 $0.00 $0
2026-04-15 MIZELL STEVEN A-Award 396.00 $49.79 $19,717
2026-04-15 CHASE WILLIAM J A-Award 408.00 $49.79 $20,314
2026-04-15 SUMME GREGORY L A-Award 631.00 $49.79 $31,417
2026-04-08 Freidin Aaron S-Sale 45,806.00 $49.92 $2.3M
2026-04-08 RAGUSA ROBERT P S-Sale 123,502.00 $49.92 $6.2M
2026-04-08 Ofman Joshua J. S-Sale 61,665.00 $49.92 $3.1M
2026-03-05 Freidin Aaron S-Sale 655.00 $53.01 $34,722
2026-03-09 Freidin Aaron S-Sale 2,407.00 $47.93 $115,368
2026-03-09 Freidin Aaron S-Sale 85.00 $46.74 $3,973
2026-03-05 Ofman Joshua J. S-Sale 690.00 $53.01 $36,577
2026-03-09 Ofman Joshua J. S-Sale 2,836.00 $47.93 $135,929
2026-03-09 Ofman Joshua J. S-Sale 101.00 $46.74 $4,721
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for GRAL — it's generated by the pipeline (market-narrative step).
Community AI Feedback
No community reviews yet for GRAL. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.373 · 697c9e64 · 2026-07-02 20:17:59